---
title: "THEA PHARMACEUTICALS LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e1a8dc41-3e4e-5b4c-8ded-81124201e2fe
json: https://whiteintel.dev/api/public/dossier/e1a8dc41-3e4e-5b4c-8ded-81124201e2fe
identifier: oo:GB-COH-06505496
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# THEA PHARMACEUTICALS LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-06505496`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e1a8dc41-3e4e-5b4c-8ded-81124201e2fe  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e1a8dc41-3e4e-5b4c-8ded-81124201e2fe  

## Ownership & control

### Owners / controllers

- **Mr Philip Lewis-Williams** (beneficial owner) — https://whiteintel.dev/entity/bdfb71cd-b993-52c4-9181-0c9186241e21
- **Mr Philip Lewis-Williams** (beneficial owner) — https://whiteintel.dev/entity/614dc215-2487-4767-bc97-d30125e9319c
- **Laboratoires Thea Sas** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/b5435bf6-b34a-4c79-8d17-ba4e3550c905

### UBO chain (walk to the ultimate owner)

A **3-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `06505496`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2008-02-15
- **Registered office:** Ic5 Building Innovation Way, Keele, Newcastle, ST5 5NT, England
- **SIC:** 46460

### Officers

- AINLEY, Christopher — secretary · appointed 2014-06-10
- MUSTAHSIN, Sheema — director · British · appointed 2023-08-25
- WILLIAMS, Philip Lewis — director · British · appointed 2008-05-12
- GEDDES, Andrew Gordon — secretary · British · appointed 2008-04-17 · resigned 2008-12-23
- SNELSON, Ian Martin — secretary · appointed 2010-09-15 · resigned 2014-06-10
- TRASK, Christopher James — secretary · British · appointed 2008-12-23 · resigned 2010-09-15
- COBBETTS (SECRETARIAL) LIMITED — corporate secretary · appointed 2008-02-15 · resigned 2008-04-17
- BAKER, Andrew Frances — director · British · appointed 2008-04-17 · resigned 2014-06-10
- CHIBRET, Henri — director · French · appointed 2008-12-23 · resigned 2023-08-25
- CHIBRET, Jean-Frederic — director · French · appointed 2008-12-23 · resigned 2023-08-25
- GEDDES, Andrew Gordon — director · British · appointed 2008-04-17 · resigned 2014-06-10
- PONCHON, David — director · French · appointed 2008-12-23 · resigned 2023-08-25
- COBBETTS (DIRECTOR) LIMITED — corporate director · appointed 2008-02-15 · resigned 2008-04-17

### Beneficial owners (Persons with Significant Control)

- [Laboratoires Thea Sas](https://whiteintel.dev/entity/b5435bf6-b34a-4c79-8d17-ba4e3550c905) — 75–100% shares · corporate PSC · France — since 2016-04-06
- Mr Philip Lewis-Williams — significant influence or control · individual PSC · England — ceased 2026-02-28

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/06505496
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/06505496

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **THEA PHARMACEUTICALS LIMITED**. Human view: https://whiteintel.dev/entity/e1a8dc41-3e4e-5b4c-8ded-81124201e2fe · Structured JSON: https://whiteintel.dev/api/public/dossier/e1a8dc41-3e4e-5b4c-8ded-81124201e2fe._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._